Hepion Pharmaceuticals, Inc. (HEPA)
0.066
-0.01
(-7.11%)
USD |
OTCM |
Sep 03, 16:00
Hepion Pharmaceuticals Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.0203 |
| September 30, 2025 | 0.0645 |
| June 30, 2025 | 0.0979 |
| March 31, 2025 | 0.1351 |
| December 31, 2024 | -1.556 |
| September 30, 2024 | -5.468 |
| June 30, 2024 | 0.0433 |
| March 31, 2024 | 0.0233 |
| December 31, 2023 | 0.0287 |
| September 30, 2023 | 0.0149 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.0011 |
| September 30, 2022 | 0.0018 |
| June 30, 2022 | 0.0026 |
| March 31, 2022 | 0.0029 |
| December 31, 2021 | 0.0034 |
| September 30, 2021 | 0.0037 |
| June 30, 2021 | 0.0041 |
| March 31, 2021 | 0.0059 |
| December 31, 2020 | 0.0186 |
| September 30, 2020 | 0.063 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.0475 |
| March 31, 2020 | 0.0397 |
| December 31, 2019 | 0.0499 |
| September 30, 2019 | 0.0605 |
| June 30, 2019 | 0.0823 |
| March 31, 2019 | 4.084 |
| December 31, 2018 | 0.7291 |
| September 30, 2018 | 0.4447 |
| June 30, 2018 | -2.661 |
| March 31, 2018 | 0.00 |
| September 30, 2017 | |
| March 31, 2017 | |
| June 30, 2016 | 0.0079 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | -0.7244 |
| September 30, 2013 | -1.037 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Johnson & Johnson | 0.5771 |
| Eli Lilly & Co. | 1.621 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.927M |
| Total Liabilities (Quarterly) | 0.6489M |
| Shareholders Equity (Quarterly) | 1.278M |
| Current Ratio | 3.911 |
| Net Debt Paydown Yield | 5.33% |